These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23670265)

  • 1. [Clinical studies in oncology--a challenge for clinical and academic pathology].
    Röcken C
    Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265
    [No Abstract]   [Full Text] [Related]  

  • 2. Early phase clinical trials in pediatric hematology and oncology.
    Corbacioglu S
    Klin Padiatr; 2012 Apr; 224(3):197-200. PubMed ID: 22511313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hospital network in pediatric oncology].
    Doz F
    Arch Pediatr; 2006 Jun; 13(6):635-7. PubMed ID: 16697587
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs.
    Amir E; Seruga B; Martinez-Lopez J; Kwong R; Pandiella A; Tannock IF; Ocaña A
    J Clin Oncol; 2011 Jun; 29(18):2543-9. PubMed ID: 21606435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The future of uro-oncology: what needs to be done to secure its place in the field of urology?].
    Albers P; Gschwend J; Hakenberg O
    Urologe A; 2011 Aug; 50(8):914-6. PubMed ID: 21735269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 7. Japanese universal health care faces a crisis in cancer treatment.
    Fujiwara Y; Yonemori K; Shibata T; Okita N; Ushirozawa N
    Lancet Oncol; 2015 Mar; 16(3):251-2. PubMed ID: 25752548
    [No Abstract]   [Full Text] [Related]  

  • 8. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug development in paediatric oncology].
    Benninger-Döring G; Boos J
    Klin Padiatr; 2006; 218(3):152-6. PubMed ID: 16688671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy for thyroid cancer: An updated review of investigational agents.
    Deshpande HA; Gettinger SN; Sosa JA
    Curr Opin Investig Drugs; 2010 Jun; 11(6):661-8. PubMed ID: 20496261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 13. SOP 08: Reporting of adverse events.
    Onkologie; 2003 Oct; 26 Suppl 6():41-2. PubMed ID: 23570185
    [No Abstract]   [Full Text] [Related]  

  • 14. SOP 13: Pharmacokinetic data analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():56-9. PubMed ID: 23570190
    [No Abstract]   [Full Text] [Related]  

  • 15. Era of personalized medicine may herald end of soaring cancer costs.
    Keogh B
    J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assessment of novel antidiabetic drugs in Germany. Do innovations still have a chance?].
    Gallwitz B
    MMW Fortschr Med; 2014 Jul; 156(13):57-60. PubMed ID: 25318228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials].
    Graf N; Göbel U
    Klin Padiatr; 2004; 216(3):129-31. PubMed ID: 15175956
    [No Abstract]   [Full Text] [Related]  

  • 18. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluating the effectiveness of drugs. "The full potential of a therapy is often only clear after a number of years" (interview by Helmut Laschet)].
    Pfundner H
    MMW Fortschr Med; 2010 Dec; 152(51-52):10. PubMed ID: 21294362
    [No Abstract]   [Full Text] [Related]  

  • 20. [HTA-Perspective: Challenges in the early assessment of new oncological drugs].
    Wild C; Nachtnebel A
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(2):129-35. PubMed ID: 23663907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.